Cargando…
Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484144/ https://www.ncbi.nlm.nih.gov/pubmed/33576909 http://dx.doi.org/10.1007/s10689-021-00228-2 |
| _version_ | 1784577256411103232 |
|---|---|
| author | Ripperger, Tim Evans, D Gareth Malkin, David Kratz, Christian P. |
| author_facet | Ripperger, Tim Evans, D Gareth Malkin, David Kratz, Christian P. |
| author_sort | Ripperger, Tim |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8484144 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Netherlands |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84841442021-10-08 Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer Ripperger, Tim Evans, D Gareth Malkin, David Kratz, Christian P. Fam Cancer Letter to the Editor Springer Netherlands 2021-02-12 2021 /pmc/articles/PMC8484144/ /pubmed/33576909 http://dx.doi.org/10.1007/s10689-021-00228-2 Text en © The Author(s) 2021, corrected publication: February 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Ripperger, Tim Evans, D Gareth Malkin, David Kratz, Christian P. Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer |
| title | Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer |
| title_full | Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer |
| title_fullStr | Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer |
| title_full_unstemmed | Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer |
| title_short | Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer |
| title_sort | choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484144/ https://www.ncbi.nlm.nih.gov/pubmed/33576909 http://dx.doi.org/10.1007/s10689-021-00228-2 |
| work_keys_str_mv | AT rippergertim chooseandstayononeoutoftwopathsdistinctionbetweenclinicalversusresearchgenetictestingtoidentifycancerpredispositionsyndromesamongpatientswithcancer AT evansdgareth chooseandstayononeoutoftwopathsdistinctionbetweenclinicalversusresearchgenetictestingtoidentifycancerpredispositionsyndromesamongpatientswithcancer AT malkindavid chooseandstayononeoutoftwopathsdistinctionbetweenclinicalversusresearchgenetictestingtoidentifycancerpredispositionsyndromesamongpatientswithcancer AT kratzchristianp chooseandstayononeoutoftwopathsdistinctionbetweenclinicalversusresearchgenetictestingtoidentifycancerpredispositionsyndromesamongpatientswithcancer |